Role of the Autonomic Nervous System in HIV-Lipodystrophy
Autonomic Nervous System Activity in the Pathogenesis of the Lipodystrophy Syndrome in HIV-Infected Patients.
1 other identifier
observational
54
1 country
1
Brief Summary
The study aims to characterise the influence of the autonomic nervous system activity on the development of the lipodystrophy syndrome in HIV-infected patients by measuring heart rate variability and various metabolic pathways in HIV patients receiving highly active antiretroviral therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 6, 2005
CompletedFirst Posted
Study publicly available on registry
September 8, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2007
CompletedMay 12, 2008
May 1, 2008
September 6, 2005
May 6, 2008
Conditions
Eligibility Criteria
Patients with confirmed HIV infection and no active opportunistic infection during the last 2 months.
You may qualify if:
- HIV-infection
- Age above 18 years
- No AIDS defining event during last 6 months
- No infection during last 6 weeks
- No concommitant drug interfering with insulin sensitivity and ANS-activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hannover Medical Schoollead
- Hector-Stiftungcollaborator
Study Sites (1)
Hannover Medical School
Hanover, 30625, Germany
Related Publications (1)
Fliers E, Sauerwein HP, Romijn JA, Reiss P, van der Valk M, Kalsbeek A, Kreier F, Buijs RM. HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet. 2003 Nov 22;362(9397):1758-60. doi: 10.1016/s0140-6736(03)14858-1.
PMID: 14643128BACKGROUND
Biospecimen
Serum and Plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georg MN Behrens, MD
Hannover Medical School
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 6, 2005
First Posted
September 8, 2005
Study Start
March 1, 2005
Study Completion
January 1, 2007
Last Updated
May 12, 2008
Record last verified: 2008-05